Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Successful Implementation of Nirsevimab and Factors Influencing Uptake in Neonatal Care
This article describes how a hospital successfully used nirsevimab to prevent RSV in newborns. They offered the immunization to 99% of eligible infants, with 71% …
Ask aRCie
Nirsevimab and Abrysvo Update for the 2024-2025 Respiratory Season
2024
· Ohio Department of Health
This webpage provides an update on both infant nirsevimab (Beyfortus®) and maternal RSVpreF (Abrysvo™) administration and planning considerations. Infants can be protected against RSV through …
Parent Perspectives on Nirsevimab for Their Newborn
2024
· Yale School of Medicine,
· Yale University
This article explores how parents feel about using nirsevimab for their newborns. Nirsevimab is a medicine that helps protect babies from RSV, a common virus …
Interim Immunization Protocol (RSV)
2025
· Oregon Health Authority
The Interim Immunization Protocol for RSV vaccines Abrysvo, Arexvy, and mResvia outlines guidelines for use. It describes the vaccine schedule, who should get vaccinated (pregnant …
Respiratory Viruses Vaccine Recommendations
This site provides vaccine recommendations for respiratory viruses like COVID-19, flu, and RSV. It describes who should get vaccinated and when. Everyone 6 months and …
Estimates: Nirsevimab 89% Effective Against RSV in Kids, 93% Against Hospitalization
2024
· University of Minnesota
This news brief describes the effectiveness of nirsevimab, a monoclonal antibody drug, in protecting children under 5 from RSV. The drug is 89% effective against …
Studies Show More Promising Results for RSV Drug Nirsevimab
2024
· University of Minnesota
This blog post describes two studies showing that the RSV drug nirsevimab is effective in protecting infants from respiratory syncytial virus. The first study found …
Respiratory Syncytial Virus Vaccine and Nirsevimab Uptake Among Pregnant People and Their Neonates
This study was conducted to describe the uptake of the prenatal RSVpreF vaccine and infant nirsevimab during the 2023-2024 RSV season. It found high uptake …
Maternal RSVpreF and Infant Nirsevimab Immunizations Uptake During Respiratory Syncytial Virus Season
This research letter looks at a study that analyzed the uptake of RSVpreF vaccination during pregnancy and nirsevimab administration to infants during the 2023 to …
Does Nirsevimab Prevent Lower Respiratory Infections Caused by Respiratory Syncytial Virus?
2024
· University of Virginia
This study examines nirsevimab, a monoclonal antibody that helps prevent respiratory syncytial virus (RSV) infections in infants. It found that one injection of nirsevimab significantly …